Analysts expect Palvella Therapeutics, Inc. to report revenue of 2.16 M for Q2 24, against a range of 1.96 M to 2.36 M. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 2.36 M | 1.15 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.63 M | 4.03 M | 27.94 M | |||||||||||
| Low Estimate | 1.96 M | 1.04 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.24 M | 3.34 M | 23.45 M | |||||||||||
| Consensus Estimate | 2.16 M | 1.10 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.44 M | 3.69 M | 25.69 M |
Analysts expect Palvella Therapeutics, Inc. to report earnings per share of -2.49 for Q2 24, against a range of -2.62 to -2.36. The most recent reported quarter, Q2 26, came in at -1.52, a 33.3% miss against the -1.14 consensus.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | -1.18 | -0.74 | -0.86 | -1.03 | -1.08 | -1.20 | -1.52 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -2.36 | -3.86 | -1.12 | -0.74 | -0.78 | -0.91 | -0.94 | -1.07 | -1.76 | -1.89 | -2.22 | -2.74 | -2.09 | -2.49 | -1.52 | |||||||||||
| Low Estimate | -2.62 | -4.68 | -1.24 | -0.80 | -0.86 | -1.03 | -1.06 | -1.21 | -1.96 | -2.23 | -2.56 | -3.20 | -2.37 | -2.67 | -1.72 | |||||||||||
| Consensus Estimate | -2.49 | -4.27 | -1.18 | -0.77 | -0.82 | -0.97 | -1.00 | -1.14 | -1.86 | -2.06 | -2.39 | -2.97 | -2.23 | -2.58 | -1.62 |
Pull Wall Street consensus for Palvella Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PVLA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PVLA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PVLA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();